Cerebral Angiography Market, By Imaging Technique (Digital Subtraction Angiography (DSA), Magnetic Resonance Angiography (MRA), Computed Tomography Angiography (CTA), Catheter Angiography, and Intraoperative Angiography), By Application, By Patient Age, By Indication, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV4927
|
Published Date
March 2026
|
Pages
295
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Cerebral Angiography Market size was valued at US$ 1,358.91 Million in 2025, expanding at a CAGR of 6.70% from 2026 to 2033.
Cerebral Angiography is a diagnostic imaging technique in which a contrast agent is introduced into the arterial system, and X-ray images are acquired to visualize the blood vessels of the brain. This procedure allows clinicians to detect vascular abnormalities, including aneurysms, arteriovenous malformations (AVMs), and occlusions, with high resolution and precision. Cerebral angiography is also used for detailed assessment of cerebral vasculature and is often integrated into treatment planning and endovascular interventions. At the public health level, government and global health data highlight that cerebrovascular diseases, particularly stroke, represent a significant health burden and a key driver of demand for advanced neurovascular imaging. The World Health Organization (WHO) recognizes stroke as one of the leading causes of death and disability worldwide. Its persistent incidence and prevalence underscore the importance of accurate vascular imaging in clinical pathways and health system planning, reinforcing the central role of cerebral angiography in diagnosis and intervention.
Cerebral Angiography Market- Market Dynamics
Rising Global Burden of Stroke and Cerebrovascular Diseases
The rising prevalence of stroke and other cerebrovascular conditions is a key driver of demand for cerebral angiography procedures. This imaging technique is widely used to visualize the brain’s blood vessels and diagnose abnormalities such as aneurysms, vascular malformations, and arterial blockages, which can lead to stroke.
As global stroke incidence increases, healthcare systems require advanced imaging tools to support accurate diagnosis and effective treatment planning. According to the World Health Organization (WHO), millions of new stroke cases occur worldwide each year, with millions of people living with the condition globally. The WHO also reports that one in four adults is expected to experience a stroke during their lifetime, underscoring the growing need for diagnostic imaging in neurological care. Because cerebral angiography provides high-resolution images of cerebral vasculature, hospitals and neurovascular centers increasingly rely on it to confirm vascular abnormalities and plan interventional procedures. As national health statistics continue to report rising cases of stroke and related vascular disorders, the demand for accurate neurovascular imaging technologies is expected to drive further adoption of cerebral angiography systems in healthcare facilities.
Cerebral Angiography Market- Segmentation Analysis:
The Global Cerebral Angiography Market is segmented on the basis of Imaging Technique, Application, Patient Age, Indication, End User, and Region.
Market Segmentation by Imaging Technique
The cerebral angiography market is segmented into four imaging techniques: Digital Subtraction Angiography (DSA), Magnetic Resonance Angiography (MRA), Computed Tomography Angiography (CTA), and Catheter Angiography. Among these, DSA continues to hold a prominent position due to its ability to provide highly detailed, real-time images of cerebral blood vessels, making it particularly effective for detecting aneurysms, arteriovenous malformations (AVMs), and vascular narrowing.
While non-invasive techniques such as MRA and CTA are gaining traction, DSA remains indispensable for complex cases and surgical planning. Public health guidance supports its use: the American Heart Association (AHA) reports hundreds of thousands of strokes in the U.S. each year, emphasizing the need for precise vascular imaging, and the UK’s National Health Service (NHS) recommends DSA for cases requiring accurate vascular mapping during interventions. These factors collectively underscore DSA’s continued prominence in clinical practice.
Market Segmentation by Application
The market is also segmented by application into Neurology, Neurosurgery, and Interventional Radiology. The Neurology segment is the most significant, as cerebral angiography is widely used to diagnose and monitor cerebrovascular conditions such as stroke, aneurysms, and AVMs. By providing detailed images of brain blood vessels, cerebral angiography enables neurologists to make timely diagnoses and manage neurovascular disorders effectively, with early detection being critical for preventing complications.
Public health data highlights the importance of neurological imaging: the Centers for Disease Control and Prevention (CDC) reports that hundreds of thousands of people in the U.S. experience a stroke each year, including a substantial number of first-time cases, while the World Health Organization (WHO) notes that cerebrovascular diseases account for millions of deaths globally. These figures emphasize the critical role of cerebral angiography in both clinical care and public health planning, reinforcing neurology as the primary application driving market demand.
Cerebral Angiography Market- Geographical Insights
In the global cerebral angiography market, North America and Asia Pacific are key regional leaders, influenced by differences in healthcare infrastructure, disease prevalence, and technology adoption. North America accounts for the largest share, approximately 41.8%, driven by advanced healthcare systems, widespread availability of neuroimaging technologies, and significant investment in diagnostic and interventional care for cerebrovascular diseases. The high incidence of stroke in the U.S. and Canada, coupled with extensive use of CT and MRI scanners, sustains demand for detailed vascular imaging.
Asia Pacific, while currently holding a smaller share, is experiencing rapid growth due to expanding healthcare infrastructure in countries such as China and India, increasing awareness of stroke and neurovascular conditions, and government initiatives to improve access to advanced diagnostic tools. Large populations and rising numbers of stroke cases further support the adoption of cerebral angiography in the region. These trends demonstrate that healthcare capacity, disease burden, and public-sector support are key factors influencing the adoption and growth of cerebral angiography across different regions.
Cerebral Angiography Market- Country Insights
Worldwide, the United States holds a strong position in the cerebral angiography market, driven by widespread adoption of advanced neuroimaging technologies and the need for precise vascular diagnosis. The country faces a significant burden of stroke and other cerebrovascular conditions. According to the Centers for Disease Control and Prevention (CDC), hundreds of thousands of people in the U.S. experience a stroke each year, including a substantial number of first-time cases, with approximately 87% being ischemic strokes that require accurate imaging for effective treatment. These statistics underscore the demand for cerebral angiography, which provides detailed visualization of cerebral blood vessels, enabling clinicians to detect vascular abnormalities and support informed clinical decision-making. The combination of high disease prevalence, a robust healthcare infrastructure, and access to advanced imaging systems reinforces the United States’ leading role in the global cerebral angiography market.
Cerebral Angiography Market- Competitive Landscape:
The cerebral angiography market is characterized by several established medical imaging and device companies offering advanced angiography systems, software, and supporting technologies for high-resolution visualization of cerebral blood vessels and optimized clinical workflows. Leading global players such as GE Healthcare, Siemens Healthineers, Philips Healthcare, and Canon Medical Systems are recognized for their comprehensive cerebral angiography solutions and ongoing enhancements in imaging quality and clinical support. Other notable contributors, including Shimadzu Corporation, Boston Scientific Corporation, AngioDynamics, and Medtronic, provide specialized products tailored to diverse healthcare settings. These companies maintain their market presence through continuous research and development, extensive distribution networks, and product updates that meet evolving clinical demands, particularly for diagnosing and managing neurovascular diseases like stroke, which remains a priority for public health authorities and national healthcare planning.
Recent Developments:
- In December 2025, Stratasys announced the full commercial availability of its RadioMatrix radiopaque 3D printing material across the U.S. This material enables healthcare providers and researchers to create patient-specific models with tunable X-ray visibility for imaging, training, and procedural planning. The innovation is expected to improve medical education, enhance pre-procedural planning, and support more accurate simulations, ultimately contributing to better patient outcomes.
- In February 2025, the FDA granted 510(k) clearance to RapidAI’s Lumina 3D software, which delivers AI-powered 3D CTA reconstructions of head and neck scans within minutes. This advancement improves visualization, accelerates neuroradiology workflows, and enhances clinical decision-making, supporting faster and more precise patient care in neurovascular imaging.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CEREBRAL ANGIOGRAPHY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- GE Healthcare
- Siemens Healthineers
- Koninklijke Philips N.V.
- Shimadzu Corp.
- Canon Medical Systems Corporation
- Samsung Medison
- St. Jude Medical, Inc.
- Hitachi Medical Corporation
- TERUMO Corporation
- Medtronic plc
- Stryker Corporation
- AngioDynamic, Inc.
- Penumbra, Inc.
- MicroPort Scientific Corporation
- Cordis
- Cook Medical LLC
GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY IMAGING TECHNIQUE- MARKET ANALYSIS, 2020 - 2033
- Digital Subtraction Angiography (DSA)
- Magnetic Resonance Angiography (MRA)
- Computed Tomography Angiography (CTA)
- Catheter Angiography
- Intraoperative Angiography
GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 – 2033
- Neurology
- Neurosurgery
- Interventional Radiology
- Others
GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY PATIENT AGE- MARKET ANALYSIS, 2020 - 2033
- Adult Patients
- Pediatric Patients
GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY INDICATION- MARKET ANALYSIS, 2020 - 2033
- Stroke
- Aneurysm
- Arteriovenous Malformation (AVM)
- Carotid Artery Disease
- Brain Tumors
GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Hospitals
- Diagnostic Imaging Centers
- Specialty Neurology Clinics
- Research Institution
- Ambulatory Surgical Centers
GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Cerebral Angiography Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Cerebral Angiography Market Snippet by Imaging Technique
2.1.2. Cerebral Angiography Market Snippet by Application
2.1.3. Cerebral Angiography Market Snippet by Patient Age
2.1.4. Cerebral Angiography Market Snippet by Indication
2.1.5. Cerebral Angiography Market Snippet by End User
2.1.6. Cerebral Angiography Market Snippet by Country
2.1.7. Cerebral Angiography Market Snippet by Region
2.2. Competitive Insights
3. Cerebral Angiography Key Market Trends
3.1. Cerebral Angiography Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Cerebral Angiography Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Cerebral Angiography Market Opportunities
3.4. Cerebral Angiography Market Future Trends
4. Cerebral Angiography Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Cerebral Angiography Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Cerebral Angiography Market Landscape
6.1. Cerebral Angiography Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Cerebral Angiography Market – By Imaging Technique
7.1. Overview
7.1.1. Segment Share Analysis, By Imaging Technique, 2025 & 2033 (%)
7.1.2. Digital Subtraction Angiography (DSA)
7.1.3. Magnetic Resonance Angiography (MRA)
7.1.4. Computed Tomography Angiography (CTA)
7.1.5. Catheter Angiography
7.1.6. Intraoperative Angiography
8. Cerebral Angiography Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
8.1.2. Neurology
8.1.3. Neurosurgery
8.1.4. Interventional Radiology
8.1.5. Others
9. Cerebral Angiography Market – By Patient Age
9.1. Overview
9.1.1. Segment Share Analysis, By Patient Age, 2025 & 2033 (%)
9.1.2. Adult Patients
9.1.3. Pediatric Patients
10. Cerebral Angiography Market – By Indication
10.1. Overview
10.1.1. Segment Share Analysis, By Indication, 2025 & 2033 (%)
10.1.2. Stroke
10.1.3. Aneurysm
10.1.4. Arteriovenous Malformation (AVM)
10.1.5. Carotid Artery Disease
10.1.6. Brain Tumors
11. Cerebral Angiography Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
11.1.2. Hospitals
11.1.3. Diagnostic Imaging Centers
11.1.4. Specialty Neurology Clinics
11.1.5. Research Institution
11.1.6. Ambulatory Surgical Centers
12. Cerebral Angiography Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
12.2. North America
12.2.1. Overview
12.2.2. Cerebral Angiography Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.2.4. North America Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.6. North America Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.2.7. North America Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Cerebral Angiography Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Cerebral Angiography Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Cerebral Angiography Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Cerebral Angiography Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13. Key Vendor Analysis- Cerebral Angiography Industry
13.1. Competitive Benchmarking
13.1.1. Competitive Dashboard
13.1.2. Competitive Positioning
13.2. Company Profiles
13.3. GE Healthcare
13.4. Siemens Healthineers
13.5. Koninklijke Philips N.V.
13.6. Shimadzu Corp.
13.7. Canon Medical Systems Corporation
13.8. Samsung Medison
13.9. St. Jude Medical, Inc.
13.10. Hitachi Medical Corporation
13.11. TERUMO Corporation
13.12. Medtronic plc
13.13. Stryker Corporation
13.14. AngioDynamic, Inc.
13.15. Penumbra, Inc.
13.16. MicroPort Scientific Corporation
13.17. Cordis
13.18. Cook Medical LLC
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CEREBRAL ANGIOGRAPHY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- GE Healthcare
- Siemens Healthineers
- Koninklijke Philips N.V.
- Shimadzu Corp.
- Canon Medical Systems Corporation
- Samsung Medison
- St. Jude Medical, Inc.
- Hitachi Medical Corporation
- TERUMO Corporation
- Medtronic plc
- Stryker Corporation
- AngioDynamic, Inc.
- Penumbra, Inc.
- MicroPort Scientific Corporation
- Cordis
- Cook Medical LLC
GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY IMAGING TECHNIQUE- MARKET ANALYSIS, 2020 - 2033
- Digital Subtraction Angiography (DSA)
- Magnetic Resonance Angiography (MRA)
- Computed Tomography Angiography (CTA)
- Catheter Angiography
- Intraoperative Angiography
GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 – 2033
- Neurology
- Neurosurgery
- Interventional Radiology
- Others
GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY PATIENT AGE- MARKET ANALYSIS, 2020 - 2033
- Adult Patients
- Pediatric Patients
GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY INDICATION- MARKET ANALYSIS, 2020 - 2033
- Stroke
- Aneurysm
- Arteriovenous Malformation (AVM)
- Carotid Artery Disease
- Brain Tumors
GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Hospitals
- Diagnostic Imaging Centers
- Specialty Neurology Clinics
- Research Institution
- Ambulatory Surgical Centers
GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
